Research and development is core of our work – we use our know-how to solve scientific tasks in drug delivery, material science and tissue engineering. Our RnD team is made of mix of skilled and young researchers with aim to exploit power of nanotechnology for better society.
Know-How & Technologies
Our research team is further powered by expertise of our engineers – we are skilled in advanced CNC manufacture, 3D printing and electronic engineering.
InoCure RnD premises are equipped with necessary infrastructure to develop novel systems using electrostatic and polymer chemistry methods. We are developing advanced nanoparticle, nanofiber and scaffolding systems using electrospinning, electrospraying, spray drying, liposome formation and emulsification methods. The systems are characterized using spectroscopic (i.e. FTIR, fluorescence and UV-Vis spectroscopic methods), optical (i.e. scanning electron microscopy) and material science (i.e. dynamic light scattering, viscosimetry) methods.
InoCure delivers solutions for following application fields:
- Tissue engineering – development of scaffolds and nanosystems delivering active molecules. Our key focus is on polymeric systems, which are formed and characterized by our researchers. InoCure researcher have experience with development of both cell-based and cell-free tissue engineering scaffolds.
- Drug delivery – either you need localized or systemic delivery our researchers can suggest delivery system for you. Our nano/microparticles are based on liposomes, emulsions, electrospraying or spray drying methods. In addition, we are able to deliver drug-releasing membranes based on electrospinning methods.
- 3D cell culture – InoCure delivers systems for 3D cell culture based on nanofibers, microfibers, short fibers or nanoparticles. Our InoSPIN device enables formation of scaffolds for most challenging 3D cell culture applications.
- Technical applications – our researchers have experience in development of coatings, non-woven textiles and 3D printed systems. Our systems are compatible with fillers and inorganic nanoparticles for broad range of applications – i.e. energy, green fuel, electronics.
NanoBAT – H2020 project (No. 691061) focused on development of novel nanoparticles for obesity treatment using L-menthol as active molecule. Project utilezes our µSphere technology for regulated release of active molecules.
NanoFEED – H2020 project (No. 778098) focused on development of nano and microparticles for improved delivery of nutrients in livestock production. Project is powered by our formulation scientists which develop advanced particles using core/shell spray drying and electrospraying.
transMed – H2020 project (No. 765441) focused on development of novel solutions for heriditary retinal diseases using innovative nanoparticles and drugs. Our researchers develop novel GMP-compliant nanoparticles and devices for delivery of cGMP inhibitors to retinal cells.
iP-OSTEO – H2020 project (No. 824007) focused on development of novel cell-based scaffolds for bone and cartilage repair based on iPSCs in patients with poor regenerative capacity. We are developing advance cell-based and cell-free scaffolds governing growth and regeneration of bone tissue.
I-DireCT – H2020 project (No. 813871) focused on development novel cancer immunotherapies using bi-functional antibodies and nanoparticles. InoCure delivers polymeric nanoparticles for targeted delivery to tumour site. Our unique µSphere technology enables formulation of solid-dosage forms for sensitive therapeutic antibodies protecting their bioaktivity.
DifMATRIX – SME Instrument (No. 808524) development of next generation 3D models using advanced nanofibers. Project helped in development of business plan for our advanced 3D cell culture membranes.